AZBio News for March 2011

Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement

Ventana Medical Launches Virtuoso Software for Digital Pathology

Catalyst for Growth – AZ Bio moves forward with new CEO and an aggressive agenda

Gore Reports First Patient Treated in the U.S. using GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a Lower Profile Delivery System

MSDx Awarded $226,000 Arizona Commerce Authority Grant

AdvaMed Appoints Regenesis Biomedical Chief Executive to Board of Directors

Posted in AZBio News and tagged , , , .